🇺🇸 FDA
Pipeline program

Conventional therapy + S (+)-Ketamine

SAFE-SK-C

Approved small_molecule active

Quick answer

Conventional therapy + S (+)-Ketamine for S-ketamine is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
S-ketamine
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials